Proximagen Company

Proximagen is a publicly traded neuroscience research company focused on drug development for neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease.

Investors

Technology: Drug Discovery
Industry: Personalized Medicine
Headquarters: London, England, United Kingdom
Founded Date: 2003
Employees Number: 11-50
Funding Status: N/A

Visit Website
info@proximagen.com
Register and Claim Ownership